BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38819403)

  • 1. Hybrid Cas12a Variants with Relaxed PAM Requirements Expand Genome Editing Compatibility.
    Liu Z; Liu H; Huang C; Zhou Q; Luo Y
    ACS Synth Biol; 2024 Jun; 13(6):1809-1819. PubMed ID: 38819403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved CRISPR-Cas12a-assisted one-pot DNA editing method enables seamless DNA editing.
    Wang L; Wang H; Liu H; Zhao Q; Liu B; Wang L; Zhang J; Zhu J; Bao R; Luo Y
    Biotechnol Bioeng; 2019 Jun; 116(6):1463-1474. PubMed ID: 30730047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the scope of plant genome engineering with Cas12a orthologs and highly multiplexable editing systems.
    Zhang Y; Ren Q; Tang X; Liu S; Malzahn AA; Zhou J; Wang J; Yin D; Pan C; Yuan M; Huang L; Yang H; Zhao Y; Fang Q; Zheng X; Tian L; Cheng Y; Le Y; McCoy B; Franklin L; Selengut JD; Mount SM; Que Q; Zhang Y; Qi Y
    Nat Commun; 2021 Mar; 12(1):1944. PubMed ID: 33782402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplexed conditional genome editing with Cas12a in
    Port F; Starostecka M; Boutros M
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22890-22899. PubMed ID: 32843348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering of a high-fidelity Cas12a nuclease variant capable of allele-specific editing.
    Wei J; Liu J; Wang Z; Yang Y; Tian Y; Wang S; Gao BQ; Gao S; Yang L; Tang J; Wang Y
    PLoS Biol; 2024 Jun; 22(6):e3002680. PubMed ID: 38865309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Survey of Genome Editing Activity for 16 Cas12a Orthologs.
    Zetsche B; Abudayyeh OO; Gootenberg JS; Scott DA; Zhang F
    Keio J Med; 2020 Sep; 69(3):59-65. PubMed ID: 31723075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Acidaminococcus sp. Cas12a nuclease recognizes GTTV and GCTV as non-canonical PAMs.
    Jacobsen T; Liao C; Beisel CL
    FEMS Microbiol Lett; 2019 Apr; 366(8):. PubMed ID: 31004485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined genome editing and transcriptional repression for metabolic pathway engineering in Corynebacterium glutamicum using a catalytically active Cas12a.
    Liu W; Tang D; Wang H; Lian J; Huang L; Xu Z
    Appl Microbiol Biotechnol; 2019 Nov; 103(21-22):8911-8922. PubMed ID: 31583448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.
    Shin HR; Kweon J; Kim Y
    Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cas12a ortholog with stringent PAM recognition followed by low off-target editing rates for genome editing.
    Chen P; Zhou J; Wan Y; Liu H; Li Y; Liu Z; Wang H; Lei J; Zhao K; Zhang Y; Wang Y; Zhang X; Yin L
    Genome Biol; 2020 Mar; 21(1):78. PubMed ID: 32213191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing CRISPR-Cas12a for Efficient Genome Editing in Yarrowia lipolytica.
    Yang Z; Xu P
    Methods Mol Biol; 2021; 2307():111-121. PubMed ID: 33847985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live-cell imaging reveals the trade-off between target search flexibility and efficiency for Cas9 and Cas12a.
    Olivi L; Bagchus C; Pool V; Bekkering E; Speckner K; Offerhaus H; Wu WY; Depken M; Martens KJA; Staals RHJ; Hohlbein J
    Nucleic Acids Res; 2024 May; 52(9):5241-5256. PubMed ID: 38647045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic Insights into the cis- and trans-Acting DNase Activities of Cas12a.
    Swarts DC; Jinek M
    Mol Cell; 2019 Feb; 73(3):589-600.e4. PubMed ID: 30639240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lb2Cas12a and its engineered variants mediate genome editing in human cells.
    Liu X; Lin L; Tang L; Xie H; Gu L; Lv X; Liu C; Zhao J; Deng R; Liu Y; Qu J; Gu F
    FASEB J; 2021 Apr; 35(4):e21270. PubMed ID: 33715215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas12a has widespread off-target and dsDNA-nicking effects.
    Murugan K; Seetharam AS; Severin AJ; Sashital DG
    J Biol Chem; 2020 Apr; 295(17):5538-5553. PubMed ID: 32161115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved genome editing by an engineered CRISPR-Cas12a.
    Ma E; Chen K; Shi H; Stahl EC; Adler B; Trinidad M; Liu J; Zhou K; Ye J; Doudna JA
    Nucleic Acids Res; 2022 Dec; 50(22):12689-12701. PubMed ID: 36537251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering of a compact, high-fidelity EbCas12a variant that can be packaged with its crRNA into an all-in-one AAV vector delivery system.
    Wang H; Zhou J; Lei J; Mo G; Wu Y; Liu H; Pang Z; Du M; Zhou Z; Paek C; Sun Z; Chen Y; Wang Y; Chen P; Yin L
    PLoS Biol; 2024 May; 22(5):e3002619. PubMed ID: 38814985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Cas12a nucleases reveals diverse PAM profiles between closely-related orthologs.
    Jacobsen T; Ttofali F; Liao C; Manchalu S; Gray BN; Beisel CL
    Nucleic Acids Res; 2020 Jun; 48(10):5624-5638. PubMed ID: 32329776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
    Hu JH; Miller SM; Geurts MH; Tang W; Chen L; Sun N; Zeina CM; Gao X; Rees HA; Lin Z; Liu DR
    Nature; 2018 Apr; 556(7699):57-63. PubMed ID: 29512652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases.
    Tóth E; Varga É; Kulcsár PI; Kocsis-Jutka V; Krausz SL; Nyeste A; Welker Z; Huszár K; Ligeti Z; Tálas A; Welker E
    Nucleic Acids Res; 2020 Apr; 48(7):3722-3733. PubMed ID: 32107556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.